Pulse Biosciences (PLSE) Work In Process (2021 - 2022)

Pulse Biosciences (PLSE) recorded quarterly Work In Process of $1.8 million in Q2 2022, up 6.68% quarter-over-quarter from $1.7 million in Q1 2022.

Pulse Biosciences (PLSE) Work In Process (2021 - 2022) Analysis & Trends

Pulse Biosciences' Work In Process history runs 2 years deep, the most recent figure standing at $1.8 million for Q2 2022.

In Q2 2022, Work In Process changed N/A year-over-year to $1.8 million; the TTM figure through Jun 2022 stood at $1.8 million (changed N/A YoY), while the FY2021 annual figure was $1.4 million, changed N/A from the prior year.
Work In Process was $1.8 million for Q2 2022 at Pulse Biosciences, up from $1.7 million in the prior quarter.
In the past five years, Work In Process ranged from a high of $1.8 million in Q2 2022 to a low of $1.2 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Pulse Biosciences	1.68 Bn	1.68 Bn	-

Download Data